CompletedNot Applicable

Extracellular Volume Associated With New-Onset Atrial Fibrillation

China589 participantsStarted 2020-01-01

Plain-language summary

Left ventricular fibrosis is strongly associated with atrial fibrillation (AF). However, the relationship between LV fibrosis and new-onset AF (NOAF) after ST-segment elevation myocardial infarction (STEMI) is currently unknown. This study was to investigate the relationship between different regions of ECV and NOAF during the acute phase of STEMI. ECV in integral (integral ECV), non-myocardial infarction region (NMI-ECV) and myocardial infarction region (MI-ECV) was obtained by CMR.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Successful pPCI (TIMI flow ≥ 2) within 12 hours after symptom onset * Admission to the cardiac care unit for continuous electrocardiogram (ECG) monitoring after pPCI Exclusion Criteria: * Poor image quality * History of myocardial infarction * History of atrial fibrillation * Malignancy, or inflammatory disease * Severe valvular heart disease * Thyroid dysfunction

What they're measuring

Primary endpoint events included new-onset atrial fibrillation

Timeframe: during hospitalization (assessed up to 10 days)

Trial details

NCT IDNCT06447857

SponsorThe Affiliated Hospital of Xuzhou Medical University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-05-31

View on ClinicalTrials.gov More Cardiac Magnetic Resonance trials